Schreiner MediPharm has developed a compact Booklet-Label for a needle protection system used in an international phase III clinical trial conducted by pharmaceutical corporation Sanofi.
Schreiner noted that, since most studies are conducted internationally, the investigational drugs must be reliably marked and provided with a complete set of information in several languages. For this purpose, Sanofi required a multi-page label making the product information available in many different languages, Schreiner noted.
In addition, the label was to firmly adhere to the plastic needle protection system without impairing the system’s functionality.